Frozen Shoulder and Acupuncture: A Clinical Guide for Practitioners and Patients

The current evidence base says yes, particularly when acupuncture is combined with structured movement therapy. A 2024 systematic review and meta-analysis in Pain Management Nursing pooled trials of acupuncture plus physical therapy versus physical therapy alone and found significantly greater improvements in pain and range of motion in the combined-treatment arm. A 2026 systematic review in Medical Acupuncture reached a similar conclusion across general shoulder pain populations. Acupuncture is best understood as a force multiplier on rehabilitation rather than a standalone fix.

Frozen shoulder is a slow condition by nature — the natural history runs 12 to 30 months untreated. A realistic acupuncture course is 8 to 16 sessions over 8 to 12 weeks, then a maintenance phase. The freezing phase responds quickest to pain modulation. The frozen (adhesive) phase needs persistent work on range of motion. The thawing phase needs the lightest touch but the most consistent home exercise. Patients who do their movement homework between sessions get there much faster than those who don't.

Several. The most common is jiān níng zhèng (肩凝症, 'congealed shoulder'). It's also called lòu jiān fēng (漏肩风, 'leaking shoulder wind'), wǔ shí jiān (五十肩, 'fifty-year-old shoulder') for the typical age of onset, and dòng jié jiān (冻结肩, 'frozen shoulder' — a direct calque). The cluster of classical names captures the pattern perfectly: a middle-aged patient whose shoulder seizes after wind-cold exposure, sleep on the affected side, or a period of overuse.

No, the two are compatible and often complementary. Cortisone reduces the inflammatory pain that limits early rehab; acupuncture, manual therapy and graded movement then extend the window of usable range. A reasonable rhythm is to begin acupuncture two to three weeks after a steroid injection, once the post-injection flare has settled, and to coordinate with the GP, rheumatologist or orthopaedic surgeon so everyone is working from the same plan. The 2026 platelet-rich plasma versus corticosteroid meta-analysis in Frontiers in Medicine is a reminder that Western options are also evolving — staying in conversation with the referring doctor matters.